The clinical effects of peramivir on influenza virus infections in infants (age; over 28 days old, under 4 years old): an open-label,non-randomized, multi-centre study.

The clinical effects of peramivir on influenza virus infections in infants (age; over 28 days old, under 4 years old): an open-label,non-randomized, multi-centre study. - The clinical effects of peramivir on influenza virus infections in infants (age; over 28 days old, under 4 years old).

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000007328

Enrollment

Registered

2012-02-21

Start date

2012-02-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Infants with Influenza virus infections.

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Guardian of the patients with informed consent. Gender: Male or female. In patients or Out patients. Age: over 28 days old, under 4 years old. Patient who must be use to intravenous peramivir for the following: Can't use oral or inhaler medicines, dehydration, chronic diseases, severe symptoms, etc,.

Exclusion criteria

Exclusion criteria: History of hypersensitivity caused by neuraminidase inhibitors. Patients who are deemed to be inappropriate by the investigator.

Design outcomes

Primary

Measure	Time frame
Time to return to normal body temperature (under 37.5 degrees).	—

Secondary

Measure	Time frame
Ratio of influenza virus-positive patients. Virus mutation after treatment of peramivir. Duration of influenza symptoms.	—

Countries

Japan

Outcome results